jnj38224342

Allergenexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Feb 1, 2010 (NCT01054352)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetImmunity, desensitized

    Immunity, desensitized

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • jnj38224342

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01054352Phase 1Feb 1, 2010Johnson and Johnson
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Johnson and JohnsonFor profit1112010
1 organizations
Page 1 / 1